Additional Infant Patient to Receive Jaguar Health’s Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS)...
The 800-Pound Gorilla in the Room: DEA Now Confirms Marijuana Production Quotas Are Coming